Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A Case Report

A 34-year-old man presented to the hospital with right-sided headache. He was diagnosed with GBM. He underwent resection of the tumor with placement of carmustine impregnated wafers. Then he underwent adjuvant chemotherapy with temozolamide. Before the completion of chemotherapy he had a recurrence....

Descripción completa

Detalles Bibliográficos
Autores principales: Vivekanandarajah, Abhirami, Krishnarasa, Balakumar, Mourad, Mervat, Aoun, Nelly, Odaimi, Marcel
Formato: Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076043/
https://www.ncbi.nlm.nih.gov/pubmed/21499558
http://dx.doi.org/10.4137/CMO.S6525
_version_ 1782201807980724224
author Vivekanandarajah, Abhirami
Krishnarasa, Balakumar
Mourad, Mervat
Aoun, Nelly
Odaimi, Marcel
author_facet Vivekanandarajah, Abhirami
Krishnarasa, Balakumar
Mourad, Mervat
Aoun, Nelly
Odaimi, Marcel
author_sort Vivekanandarajah, Abhirami
collection PubMed
description A 34-year-old man presented to the hospital with right-sided headache. He was diagnosed with GBM. He underwent resection of the tumor with placement of carmustine impregnated wafers. Then he underwent adjuvant chemotherapy with temozolamide. Before the completion of chemotherapy he had a recurrence. He underwent re-resection with placement of carmustine impregnated wafers. Subsequently he had eighteen cycles of salvage biochemotherapy with bevacizumab and irinotecan. To date, routine MRI scans of the brain have not shown evidence of recurrence. He continues to be in remission three years after treatment with bevacizumab and irinotecan.
format Text
id pubmed-3076043
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-30760432011-04-15 Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A Case Report Vivekanandarajah, Abhirami Krishnarasa, Balakumar Mourad, Mervat Aoun, Nelly Odaimi, Marcel Clin Med Insights Oncol Case Report A 34-year-old man presented to the hospital with right-sided headache. He was diagnosed with GBM. He underwent resection of the tumor with placement of carmustine impregnated wafers. Then he underwent adjuvant chemotherapy with temozolamide. Before the completion of chemotherapy he had a recurrence. He underwent re-resection with placement of carmustine impregnated wafers. Subsequently he had eighteen cycles of salvage biochemotherapy with bevacizumab and irinotecan. To date, routine MRI scans of the brain have not shown evidence of recurrence. He continues to be in remission three years after treatment with bevacizumab and irinotecan. Libertas Academica 2011-02-14 /pmc/articles/PMC3076043/ /pubmed/21499558 http://dx.doi.org/10.4137/CMO.S6525 Text en © the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited.
spellingShingle Case Report
Vivekanandarajah, Abhirami
Krishnarasa, Balakumar
Mourad, Mervat
Aoun, Nelly
Odaimi, Marcel
Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A Case Report
title Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A Case Report
title_full Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A Case Report
title_fullStr Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A Case Report
title_full_unstemmed Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A Case Report
title_short Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A Case Report
title_sort achievement of three year remission with bevacizumab and irinotecan in recurrent glioblastoma multiforme: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076043/
https://www.ncbi.nlm.nih.gov/pubmed/21499558
http://dx.doi.org/10.4137/CMO.S6525
work_keys_str_mv AT vivekanandarajahabhirami achievementofthreeyearremissionwithbevacizumabandirinotecaninrecurrentglioblastomamultiformeacasereport
AT krishnarasabalakumar achievementofthreeyearremissionwithbevacizumabandirinotecaninrecurrentglioblastomamultiformeacasereport
AT mouradmervat achievementofthreeyearremissionwithbevacizumabandirinotecaninrecurrentglioblastomamultiformeacasereport
AT aounnelly achievementofthreeyearremissionwithbevacizumabandirinotecaninrecurrentglioblastomamultiformeacasereport
AT odaimimarcel achievementofthreeyearremissionwithbevacizumabandirinotecaninrecurrentglioblastomamultiformeacasereport

Ejemplares similares